Elisa V. Luqman

CIK: 0001486189

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)3 (60.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)2 (40.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

NUTX

Nutex Health Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (5 total)

NUTX
Nutex Health Inc.
Mar 10, 2026
Exercise(M)
Indirect
2.1K shares-
NUTX
Nutex Health Inc.
Mar 10, 2026
Tax Payment(F)
Indirect
784 shares at avg. $86.22$68K
NUTX
Nutex Health, Inc.
Apr 4, 2025
Tax Payment(F)
Direct
266 shares at avg. $72.10$19K
NUTX
Nutex Health, Inc.
Mar 10, 2025
Exercise(M)
Restricted Stock Units
Direct
2.5K shares-
NUTX
Nutex Health, Inc.
Mar 1, 2025
Exercise(M)
Direct
1.3K shares-

		Type	Shares	Price		Ownership
Mar 10, 2026	NUTX Nutex Health Inc.	Exercise(M)	2,084	-	$0	Indirect
Mar 10, 2026	NUTX Nutex Health Inc.	Tax Payment(F)	784	$86.22	$67,598	Indirect
Apr 4, 2025	NUTX Nutex Health, Inc.	Tax Payment(F)	266	$72.10	$19,178	Direct
Mar 10, 2025	NUTX Nutex Health, Inc.	Exercise(M) Restricted Stock Units	2,500	-	-	Direct
Mar 1, 2025	NUTX Nutex Health, Inc.	Exercise(M)	1,250	-	-	Direct

1-5 of 5 transactions

About Luqman Elisa V

Luqman Elisa V (SEC CIK 0001486189) files insider reports with the SEC as Chief Legal Officer - SEC of Nutex Health Inc. (NUTX).

Signal8 holds 2 ownership filings by Luqman Elisa V, all Form 4s, filed between Apr 14, 2025 and Mar 11, 2026. Those filings report 5 transactions, from Mar 1, 2025 to Mar 10, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Luqman Elisa V's filings is in HOUSTON, TX.

Recent filings by Luqman Elisa V

Mar 10, 2026: Option exercise of NUTX shares (Form 4, code M).
Mar 10, 2026: Tax withholding of NUTX shares (Form 4, code F).
Apr 4, 2025: Tax withholding of NUTX shares (Form 4, code F).
Mar 10, 2025: Option exercise of NUTX derivative securities (Form 4, code M).
Mar 1, 2025: Option exercise of NUTX shares (Form 4, code M).

Other insiders filing for Nutex Health Inc. (NUTX)

Saunders Scott J, Director
Jaumot Frank E, Director
Grenas Cheryl Yvonne, Director
Reed Michael Lee, Director
Spears Kelvin, Director
Vo Thomas T., Chief Executive Officer

How to read Form 4 transaction codes